Pharmacokinetic Enhancement of Elexacaftor/Tezacaftor/Ivacaftor for Cystic Fibrosis: A Cost Reduction Strategy to Address Global Disparities in Access

Research output: Contribution to journalArticlepeer-review

4 Scopus citations
Original languageEnglish
Pages (from-to)1204-1207
Number of pages4
JournalClinical Pharmacology and Therapeutics
Volume115
Issue number6
DOIs
StatePublished - Jun 2024

Cite this